Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
GnRH signaling pathway | R-HSA-168638 | map04912 | thioproperazine | 9429 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | thioproperazine | 9429 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | thioproperazine | 9429 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | thioproperazine | 9429 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | thioproperazine | 9429 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | thioproperazine | 9429 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | thioproperazine | 9429 | drug-path |
Asthma | R-HSA-444620 | map05310 | thioproperazine | 9429 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | thioproperazine | 9429 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | thioproperazine | 9429 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | thioproperazine | 9429 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | picotamide | 4814 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | picotamide | 4814 | drug-path |
Primary immunodeficiency | R-HSA-5601905 | map05340 | picotamide | 4814 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | picotamide | 4814 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | picotamide | 4814 | drug-path |
Shigellosis | 0 | map05131 | picotamide | 4814 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | picotamide | 4814 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | picotamide | 4814 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | pirenzepine | 4848 | drug-path |